Lilly’s donanemab could bring new hope to Alzheimer’s patients in Australia following lecanemab… EP News Bureau Oct 25, 2024 Australia’s Alzheimer’s patients await potential treatment shift as TGA reviews Lilly’s donanemab following lecanemab rejection
